Mitoxantrone Injection, Solution, Concentrate
Product Images NDC 71288-179

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mitoxantrone (NDC 71288-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (mitoXANTRONE Injection USP (concentrate) 20 mg per 10 mL Carton)

Packaging label for mitoXANTRONE Injection, USP (concentrate) by Meitheal Pharmaceuticals Inc. The label shows the product strength as 20 mg per 10 mL (2 mg per mL) in a sterile 1 x 10 mL multiple-dose vial for intravenous infusion. It includes storage information, inactive ingredients, and cautions, along with a barcode and NDC 71288-178-10.*

FDA Label Image

Principal Display Panel (mitoXANTRONE Injection USP (concentrate) 20 mg per 10 mL Container Label)

Label for mitoXANTRONE Injection, USP concentrate, 20 mg per 10 mL (2 mg per mL) for intravenous infusion. This sterile, multiple-dose vial is labeled for use after dilution. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL. The label includes dosing concentration, storage instructions, and cautions about cytotoxic agent handling.*

FDA Label Image

Principal Display Panel (mitoXANTRONE Injection USP (concentrate) 25 mg per 12.5 mL Carton)

Packaging label for mitoXANTRONE Injection, USP concentrate, 25 mg per 12.5 mL (2 mg/mL), by Meitheal Pharmaceuticals Inc. The label indicates it is for intravenous infusion, sterile, in a 1 x 12.5 mL multiple-dose vial. The label includes storage instructions, inactive ingredients, handling cautions, and a barcode, with text noting pharmacist dispensing requirements and dilution instructions.*

FDA Label Image

Principal Display Panel (mitoXANTRONE Injection USP (concentrate) 25 mg per 12.5 mL Container Label)

Label for mitoXANTRONE Injection USP concentrate, 2 mg/mL (25 mg per 12.5 mL vial) by Meitheal Pharmaceuticals Inc. The label indicates intravenous infusion use after dilution, sterile multiple-dose vial, and contains storage and handling instructions for this prescription drug.*

FDA Label Image

Structure (Mito Structure)

Chemical structure of mitoXANTRONE shown as a detailed molecular diagram including hydroxyl groups, amine groups, and two hydrochloride components (2HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.